By 2017, the pharmaceutical industry in India was valued at $33 billion, with generic drugs accounting for 20 percent of global exports share in terms of volume. This made India the largest provider of generic medicines in the world. Despite large players like Piramal, Torrent, Cipla, Sun Pharma, Aurobindo,
Dr Reddy’s and Glenmark, the industry remains highly fragmented, with more than 10,000 companies. India’s pharma exports grew by 11 percent in FY19, one of its highest growth rates in the last decade.